The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Update with RXi Pharmaceuticals - Discusses Developments in the Immuno-Oncology Space and Target Indications

SNNLive caught up with Geert Cauwenbergh, Dr. Med. Sc., President and CEO of RXi Pharmaceuticals Corporation (NASDAQ: RXII) at the BIO CEO & Investor Conference 2018 in New York City, NY.

Share With

Thursday, March 22, 2018

   

© 2018 Stock News Now